Finland · Delayed Price · Currency is EUR Biohit Oyj Statistics
Total Valuation
Biohit Oyj has a market cap or net worth of EUR 40.60 million. The enterprise value is 37.34 million.
| Market Cap | 40.60M |
| Enterprise Value | 37.34M |
Important Dates
The next confirmed earnings date is Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biohit Oyj has 15.21 million shares outstanding. The number of shares has increased by 1.09% in one year.
| Current Share Class | 12.23M |
| Shares Outstanding | 15.21M |
| Shares Change (YoY) | +1.09% |
| Shares Change (QoQ) | +2.62% |
| Owned by Insiders (%) | 40.21% |
| Owned by Institutions (%) | 0.67% |
| Float | 4.50M |
Valuation Ratios
The trailing PE ratio is 14.83 and the forward PE ratio is 17.80.
| PE Ratio | 14.83 |
| Forward PE | 17.80 |
| PS Ratio | 2.58 |
| PB Ratio | 2.72 |
| P/TBV Ratio | 2.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.77, with an EV/FCF ratio of -27.39.
| EV / Earnings | 13.64 |
| EV / Sales | 2.37 |
| EV / EBITDA | 10.77 |
| EV / EBIT | 12.23 |
| EV / FCF | -27.39 |
Financial Position
The company has a current ratio of 2.56, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.56 |
| Quick Ratio | 2.34 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.46 |
| Debt / FCF | -1.17 |
| Interest Coverage | 67.82 |
Financial Efficiency
Return on equity (ROE) is 20.18% and return on invested capital (ROIC) is 24.67%.
| Return on Equity (ROE) | 20.18% |
| Return on Assets (ROA) | 10.80% |
| Return on Invested Capital (ROIC) | 24.67% |
| Return on Capital Employed (ROCE) | 18.85% |
| Weighted Average Cost of Capital (WACC) | 6.86% |
| Revenue Per Employee | 342,000 |
| Profits Per Employee | 59,522 |
| Employee Count | 46 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 5.45 |
Taxes
In the past 12 months, Biohit Oyj has paid 163,000 in taxes.
| Income Tax | 163,000 |
| Effective Tax Rate | 5.62% |
Stock Price Statistics
The stock price has increased by +6.44% in the last 52 weeks. The beta is 0.50, so Biohit Oyj's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | +6.44% |
| 50-Day Moving Average | 2.46 |
| 200-Day Moving Average | 2.97 |
| Relative Strength Index (RSI) | 67.16 |
| Average Volume (20 Days) | 9,874 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biohit Oyj had revenue of EUR 15.73 million and earned 2.74 million in profits. Earnings per share was 0.18.
| Revenue | 15.73M |
| Gross Profit | 10.75M |
| Operating Income | 3.05M |
| Pretax Income | 2.90M |
| Net Income | 2.74M |
| EBITDA | 3.13M |
| EBIT | 3.05M |
| Earnings Per Share (EPS) | 0.18 |
Balance Sheet
The company has 4.85 million in cash and 1.59 million in debt, with a net cash position of 3.26 million or 0.21 per share.
| Cash & Cash Equivalents | 4.85M |
| Total Debt | 1.59M |
| Net Cash | 3.26M |
| Net Cash Per Share | 0.21 |
| Equity (Book Value) | 14.94M |
| Book Value Per Share | 0.98 |
| Working Capital | 5.63M |
Cash Flow
In the last 12 months, operating cash flow was -748,000 and capital expenditures -615,000, giving a free cash flow of -1.36 million.
| Operating Cash Flow | -748,000 |
| Capital Expenditures | -615,000 |
| Depreciation & Amortization | 81,000 |
| Net Borrowing | -302,000 |
| Free Cash Flow | -1.36M |
| FCF Per Share | -0.09 |
Margins
Gross margin is 68.33%, with operating and profit margins of 19.40% and 17.40%.
| Gross Margin | 68.33% |
| Operating Margin | 19.40% |
| Pretax Margin | 18.44% |
| Profit Margin | 17.40% |
| EBITDA Margin | 19.91% |
| EBIT Margin | 19.40% |
| FCF Margin | n/a |
Dividends & Yields
Biohit Oyj does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.09% |
| Shareholder Yield | -1.09% |
| Earnings Yield | 6.74% |
| FCF Yield | -3.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Biohit Oyj has an Altman Z-Score of 7.85 and a Piotroski F-Score of 3.
| Altman Z-Score | 7.85 |
| Piotroski F-Score | 3 |